This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The Feinstein Institutes for Medical Research, North Shore-Long Island Jewish Research Institute. Active years: 2003-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lynbrook, NY (US) (2003 - 2010)
- Hatfield, PA (US) (2017)
Company Filing History:
3 out of 164 
1 out of 21 
Years Active: 2003-2017
Title: The Innovations of Rajendra N Damle
Introduction
Rajendra N Damle is a notable inventor based in Lynbrook, NY (US). He has made significant contributions to the field of medical research, particularly in the area of chronic lymphocytic leukemia (CLL). With a total of four patents to his name, his work has the potential to impact the prognosis and treatment of this disease.
Latest Patents
One of his latest patents focuses on the use of CD38 as a prognostic indicator in B cell chronic lymphocytic leukemia. This invention discloses a method for determining the prognosis and probable clinical course of a subject diagnosed with B-CLL. Specifically, the invention involves comparing CD38 expression in a biological sample from the subject containing B-CLL cells to a baseline level of CD38 expression. An elevated level of CD38 expression in relation to the baseline may indicate a poor prognosis or an aggressive course of the disease. Additionally, the patent includes a method for determining whether the immunoglobulin variable (Ig V) genes of the B-CLL cells are mutated. This is done by comparing CD38 expression in a biological sample, where a lower level of CD38 expression indicates an Ig V gene mutation.
Career Highlights
Rajendra N Damle has worked with prominent institutions such as the Feinstein Institute for Medical Research and North Shore-LIJ Research Institute. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Nicholas Chiorazzi and Tarun Wasil. Their collaborative efforts have further advanced the understanding of chronic lymphocytic leukemia and its treatment.
Conclusion
Rajendra N Damle's innovative work in the field of chronic lymphocytic leukemia has the potential to significantly improve patient outcomes. His patents and collaborations reflect his commitment to advancing medical research and providing valuable insights into this complex disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile